Story perspectives

Trump nominates Dr. Heidi Overton as FDA commissioner

8/20/2026

Left

Heidi Overton Nominated

U.S. President Donald Trump announced on August 19, 2026 that Dr. Heidi Overton was nominated to serve as commissioner of the Food and Drug Administration.
Overton has publicly described abortion medication as dangerous to women and advocated stricter regulation of the mifepristone pill.
The FDA is grappling with staffing shortages and recent lettuce-linked cyclosporiasis and Salmonella outbreaks.
Senator Bill Cassidy criticized the administration’s vaccine policies ahead of Overton’s confirmation hearing.

Right

Trump Nominates Overton

U.S. President Donald Trump announced on August 19 2026 that Dr. Heidi Overton is his nominee for Food and Drug Administration commissioner.
Overton’s pro-life stance was highlighted by Trump, who called her a “rockstar” problem-solver advancing an America-first health agenda.
She helped craft the August 10 order cutting vaccine schedule and ending COVID-19 shots for minors.
The appointment follows Marty Makary’s resignation, which left the FDA with 3,000 fewer staff.

Center

Trump Nominates

U.S. President Donald Trump announced on August 19, 2026 that Dr. Heidi Overton is his nominee for FDA commissioner.
Former FDA commissioner Dr. Marty Makary resigned in May 2026 after White House disputes over flavored e-cigarettes, an abortion-pill safety study, and drug-approval disagreements.
The FDA is facing staff losses, low morale, and a recent cyclospora food-borne illness outbreak.
Overton, deputy director of White House Domestic Policy Council, holds an MD, Johns Hopkins residency, PhD.

Blindspot

The White House said Overton helped craft the August 10 executive order that shortens the childhood vaccine schedule and ends the COVID-19 vaccine requirement for minors.
Within this story's sources, this angle appears mainly in Right-leaning coverage and receives less attention in Left-leaning and Center-leaning coverage.

History

Historical Context

In 1994 Roussel-Uclaf donated U.S. rights to the Population Council, which licensed Danco Laboratories in 1995; after a conditional FDA license in 1996, Danco received full approval for mifepristone (Mifeprex) on 28 September 2000. By 2023 the pill accounted for roughly 63 % of U.S. abortions, a share that revived political fights and led President Donald Trump to nominate Dr. Heidi Overton in August 2026 to impose tighter limits.

1 of 5

Heidi Overton Nominated

U.S. President Donald Trump announced on August 19, 2026 that Dr. Heidi Overton was nominated to serve as commissioner of the Food and Drug Administration.
Overton has publicly described abortion medication as dangerous to women and advocated stricter regulation of the mifepristone pill.
The FDA is grappling with staffing shortages and recent lettuce-linked cyclosporiasis and Salmonella outbreaks.
Senator Bill Cassidy criticized the administration’s vaccine policies ahead of Overton’s confirmation hearing.

1 / 5